Ruiying Zhao Department of Integrative Biology and Pharmacology, McGovern Medical School The University of Texas Health Science Center at Houston Biography Publications Institution JoVE Articles Ruiying Zhao has not added a biography. If you are Ruiying Zhao and would like to personalize this page please email our Author Liaison for assistance. Publications Establishment of a Human Embryonic Stem Cell Line with Homozygous TP53 R248W Mutant by TALEN Mediated Gene Editing Stem Cell Research. Apr, 2018 | Pubmed ID: 29730572 A Homozygous P53 R282W Mutant Human Embryonic Stem Cell Line Generated Using TALEN-mediated Precise Gene Editing Stem Cell Research. Mar, 2018 | Pubmed ID: 29414603 Generation of Human Embryonic Stem Cell Line with Heterozygous RB1 Deletion by CRIPSR/Cas9 Nickase Stem Cell Research. Apr, 2018 | Pubmed ID: 29414415 Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic P53 Trends in Pharmacological Sciences. 10, 2017 | Pubmed ID: 28818333 Osteosarcoma: Molecular Pathogenesis and IPSC Modeling Trends in Molecular Medicine. 08, 2017 | Pubmed ID: 28735817 The Histogenesis of Ewing Sarcoma Cancer Reports and Reviews. 2017 | Pubmed ID: 28626837 Osteosarcoma متلازمة لي-Fraumeni الخلايا الجذعية Pluripotent المستحث المستمدة من المريض باستخدام النمذجة Ruoji Zhou1,2, An Xu1, Jian Tu1,3, Mo Liu1, Julian A Gingold4, Ruiying Zhao1, Dung-Fang Lee1,2,5,6 1Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, 2Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth, 3Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-sen University, 4Women's Health Institute, Cleveland Clinic Foundation, 5Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, 6Center for Precision Health, School of Biomedical Informatics and School of Public Health, The University of Texas Health Science Center at Houston JoVE 57664 Cancer Research
Osteosarcoma متلازمة لي-Fraumeni الخلايا الجذعية Pluripotent المستحث المستمدة من المريض باستخدام النمذجة Ruoji Zhou1,2, An Xu1, Jian Tu1,3, Mo Liu1, Julian A Gingold4, Ruiying Zhao1, Dung-Fang Lee1,2,5,6 1Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, 2Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth, 3Department of Musculoskeletal Oncology, The First Affiliated Hospital of Sun Yat-sen University, 4Women's Health Institute, Cleveland Clinic Foundation, 5Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, 6Center for Precision Health, School of Biomedical Informatics and School of Public Health, The University of Texas Health Science Center at Houston JoVE 57664 Cancer Research
